David Pires

Scopus Author ID Loop profile Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 35

Top Venues

Microorganisms

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

Biomolecules

Universidade de Lisboa Instituto de Investigação do Medicamento

Universidade de Lisboa Faculdade de Farmacia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade de Lisboa Instituto de Investigação do Medicamento

Portugal

Investigador :: Drug Discovery - Host-Pathogen Interactions

Universidade de Lisboa Instituto de Investigação do Medicamento Jan 01 2015

Portugal

Post-Doc Fellow :: Host-Pathogen Interactions

Education History

Universidade de Lisboa Faculdade de Farmacia - Dec 16 2014

Portugal

PHD :: Microbiologia e Imunologia

Universidade de Lisboa Faculdade de Ciencias - Dec 07 2010

Portugal

MSC

Publications

Manoj Mandal, David Pires, Marta Calado, José Miguel Azevedo-Pereira, Elsa Anes
Cystatin F Depletion in Mycobacterium tuberculosis -Infected Macrophages Improves Cathepsin C/Granzyme B-Driven Cytotoxic Effects on HIV-Infected Cells during Coinfection. International journal of molecular sciences 25 (15) (2024)
Elsa Anes, José Miguel Azevedo-Pereira, David Pires
Role of Type I Interferons during Mycobacterium tuberculosis and HIV Infections. Biomolecules 14 (7) (2024)
Elsa Anes, José Miguel Azevedo-Pereira, David Pires
Role of Type I Interferons during Mycobacterium tuberculosis and HIV Infections. Biomolecules 14 (7) (2024)
Francisco Olivença, David Pires, Cátia Silveiro, Bianca Gama, Frederico Holtreman, Elsa Anes, Maria João Catalão
Ethambutol and meropenem/clavulanate synergy promotes enhanced extracellular and intracellular killing of Mycobacterium tuberculosis . Antimicrobial agents and chemotherapy (2024)
João Pedro Pais, Olha Antoniuk, David Pires, Tiago Delgado, Andreia Fortuna, Paulo J Costa, Elsa Anes, Luís Constantino
Synthesis, Activity, Toxicity, and In Silico Studies of New Antimycobacterial N -Alkyl Nitrobenzamides. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
Francisco Olivença, David Pires, Cátia Silveiro, Bianca Gama, Frederico Holtreman, Elsa Anes, Maria João Catalão
Ethambutol and meropenem/clavulanate synergy promotes enhanced extracellular and intracellular killing of Mycobacterium tuberculosis . Antimicrobial agents and chemotherapy 68 (4) (2024)
Francisco Olivença, David Pires, Cátia Silveiro, Bianca Gama, Frederico Holtreman, Elsa Anes, Maria João Catalão
Ethambutol and meropenem/clavulanate synergy promotes enhanced extracellular and intracellular killing of Mycobacterium tuberculosis . Antimicrobial agents and chemotherapy 68 (4) (2024)
Francisco Olivença, David Pires, Cátia Silveiro, Bianca Gama, Frederico Holtreman, Elsa Anes, Maria João Catalão
Ethambutol and meropenem/clavulanate synergy promotes enhanced extracellular and intracellular killing of Mycobacterium tuberculosis . Antimicrobial agents and chemotherapy 68 (4) (2024)
Elsa Anes, José Miguel Azevedo-Pereira, David Pires
Role of Type I Interferons during Mycobacterium tuberculosis and HIV Infections. Biomolecules 14 (7) (2024)
Manoj Mandal, David Pires, Marta Calado, José Miguel Azevedo-Pereira, Elsa Anes
Cystatin F Depletion in Mycobacterium tuberculosis -Infected Macrophages Improves Cathepsin C/Granzyme B-Driven Cytotoxic Effects on HIV-Infected Cells during Coinfection. International journal of molecular sciences 25 (15) (2024)
Tiago Delgado, João Pedro Pais, David Pires, Filipe G A Estrada, Rita C Guedes, Elsa Anes, Luís Constantino
Development of New Drugs to Treat Tuberculosis Based on the Dinitrobenzamide Scaffold. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
Tiago Delgado, João Pedro Pais, David Pires, Filipe G A Estrada, Rita C Guedes, Elsa Anes, Luís Constantino
Development of New Drugs to Treat Tuberculosis Based on the Dinitrobenzamide Scaffold. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
João Pedro Pais, Olha Antoniuk, David Pires, Tiago Delgado, Andreia Fortuna, Paulo J Costa, Elsa Anes, Luís Constantino
Synthesis, Activity, Toxicity, and In Silico Studies of New Antimycobacterial N -Alkyl Nitrobenzamides. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
David Pires, Manoj Mandal, Jacinta Oliveira Pinho, Maria João Catalão, António José Almeida, José Miguel Azevedo-Pereira, Maria Manuela Gaspar, Elsa Anes
Liposomal Delivery of Saquinavir to Macrophages Overcomes Cathepsin Blockade by Mycobacterium tuberculosis and Helps Control the Phagosomal Replicative Niches. International journal of molecular sciences 24 (2) (2023)
David Pires, Manoj Mandal, Jacinta Oliveira Pinho, Maria João Catalão, António José Almeida, José Miguel Azevedo-Pereira, Maria Manuela Gaspar, Elsa Anes
Liposomal Delivery of Saquinavir to Macrophages Overcomes Cathepsin Blockade by Mycobacterium tuberculosis and Helps Control the Phagosomal Replicative Niches. International journal of molecular sciences 24 (2) (2023)
Elsa Anes, David Pires, Manoj Mandal, José Miguel Azevedo-Pereira
ESAT-6 a Major Virulence Factor of Mycobacterium tuberculosis . Biomolecules 13 (6) (2023)
Elsa Anes, David Pires, Manoj Mandal, José Miguel Azevedo-Pereira
ESAT-6 a Major Virulence Factor of Mycobacterium tuberculosis . Biomolecules 13 (6) (2023)
José Miguel Azevedo-Pereira, David Pires, Marta Calado, Manoj Mandal, Quirina Santos-Costa, Elsa Anes
HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an "Emerging Syndemic". Microorganisms 11 (4) (2023)
David Pires, Manoj Mandal, Jacinta Oliveira Pinho, Maria João Catalão, António José Almeida, José Miguel Azevedo-Pereira, Maria Manuela Gaspar, Elsa Anes
Liposomal Delivery of Saquinavir to Macrophages Overcomes Cathepsin Blockade by Mycobacterium tuberculosis and Helps Control the Phagosomal Replicative Niches. International journal of molecular sciences 24 (2) (2023)
Elsa Anes, David Pires, Manoj Mandal, José Miguel Azevedo-Pereira
ESAT-6 a Major Virulence Factor of Mycobacterium tuberculosis . Biomolecules 13 (6) (2023)
João Pedro Pais, Olha Antoniuk, Raquel Freire, David Pires, Emília Valente, Elsa Anes, Luís Constantino
Nitrobenzoates and Nitrothiobenzoates with Activity against M. tuberculosis . Microorganisms 11 (4) (2023)
João Pedro Pais, Olha Antoniuk, Raquel Freire, David Pires, Emília Valente, Elsa Anes, Luís Constantino
Nitrobenzoates and Nitrothiobenzoates with Activity against M. tuberculosis . Microorganisms 11 (4) (2023)
David Pires, Manoj Mandal, Ana I Matos, Carina Peres, Maria João Catalão, José Miguel Azevedo-Pereira, Ronit Satchi-Fainaro, Helena F Florindo, Elsa Anes
Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant Mycobacterium tuberculosis . Antibiotics (Basel, Switzerland) 12 (4) (2023)
João Pedro Pais, Olha Antoniuk, Raquel Freire, David Pires, Emília Valente, Elsa Anes, Luís Constantino
Nitrobenzoates and Nitrothiobenzoates with Activity against M. tuberculosis . Microorganisms 11 (4) (2023)
José Miguel Azevedo-Pereira, David Pires, Marta Calado, Manoj Mandal, Quirina Santos-Costa, Elsa Anes
HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an "Emerging Syndemic". Microorganisms 11 (4) (2023)
David Pires, Manoj Mandal, Jacinta Oliveira Pinho, Maria João Catalão, António José Almeida, José Miguel Azevedo-Pereira, Maria Manuela Gaspar, Elsa Anes
Liposomal Delivery of Saquinavir to Macrophages Overcomes Cathepsin Blockade by Mycobacterium tuberculosis and Helps Control the Phagosomal Replicative Niches. International journal of molecular sciences 24 (2) (2023)
José Miguel Azevedo-Pereira, David Pires, Marta Calado, Manoj Mandal, Quirina Santos-Costa, Elsa Anes
HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an "Emerging Syndemic". Microorganisms 11 (4) (2023)
Marta Calado, David Pires, Carolina M Conceição, Rita Ferreira, Quirina Santos-Costa, Elsa Anes, José Miguel Azevedo-Pereira
Cell-to-Cell Transmission of HIV-1 and HIV-2 from Infected Macrophages and Dendritic Cells to CD4+ T Lymphocytes. Viruses 15 (5) (2023)
João Pedro Pais, Olha Antoniuk, Raquel Freire, David Pires, Emília Valente, Elsa Anes, Luís Constantino
Nitrobenzoates and Nitrothiobenzoates with Activity against M. tuberculosis . Microorganisms 11 (4) (2023)
José Miguel Azevedo-Pereira, David Pires, Marta Calado, Manoj Mandal, Quirina Santos-Costa, Elsa Anes
HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an "Emerging Syndemic". Microorganisms 11 (4) (2023)
David Pires, Manoj Mandal, Ana I Matos, Carina Peres, Maria João Catalão, José Miguel Azevedo-Pereira, Ronit Satchi-Fainaro, Helena F Florindo, Elsa Anes
Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant Mycobacterium tuberculosis . Antibiotics (Basel, Switzerland) 12 (4) (2023)
Manoj Mandal, David Pires, Maria João Catalão, José Miguel Azevedo-Pereira, Elsa Anes
Modulation of Cystatin F in Human Macrophages Impacts Cathepsin-Driven Killing of Multidrug-Resistant Mycobacterium tuberculosis . Microorganisms 11 (7) (2023)
João Pedro Pais, Marta Magalhães, Olha Antoniuk, Ivete Barbosa, Raquel Freire, David Pires, Emília Valente, Bernard Testa, Elsa Anes, Luís Constantino
Benzoic Acid Derivatives as Prodrugs for the Treatment of Tuberculosis. Pharmaceuticals (Basel, Switzerland) 15 (9) (2022)
João Pedro Pais, Margarida Policarpo, David Pires, Ana Paula Francisco, Ana Margarida Madureira, Bernard Testa, Elsa Anes, Luís Constantino
Fluoroquinolone Derivatives in the Treatment of Mycobacterium tuberculosis Infection. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Francisco Olivença, Alexandra Nunes, Rita Macedo, David Pires, Cátia Silveiro, Elsa Anes, Maria Miragaia, João Paulo Gomes, Maria João Catalão
Uncovering Beta-Lactam Susceptibility Patterns in Clinical Isolates of Mycobacterium tuberculosis through Whole-Genome Sequencing. Microbiology spectrum 10 (4) (2022)
David Pires, Emília Valente, Marta Filipa Simões, Nuno Carmo, Bernard Testa, Luís Constantino, Elsa Anes
Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages. Antimicrobial agents and chemotherapy 59 (12) (2015)

David Pires.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David Pires